{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:28:54Z","timestamp":1793924934009,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:00:00Z","timestamp":1793923200000},"content-version":"vor","delay-in-days":120,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-026-06248-9","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:05:13Z","timestamp":1783609513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering the genetic link between familial hypobetalipoproteinemia and neuromuscular disorder: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Lina","family":"Ly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony J.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9252-8539","authenticated-orcid":false,"given":"Linh","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"Suppl 1","key":"6248_CR1","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.6065\/apem.2244180.090","volume":"28","author":"SY Park","year":"2023","unstructured":"Park SY, et al. Case report of familial hypobetalipoproteinemia: a novel APOB mutation and literature review. Ann Pediatr Endocrinol Metab. 2023;28(Suppl 1):S9\u201311.","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"3","key":"6248_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/MOL.0000000000000072","volume":"25","author":"FK Welty","year":"2014","unstructured":"Welty FK. Hypobetalipoproteinemia and abetalipoproteinemia. Curr Opin Lipidol. 2014;25(3):161\u20138.","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"6248_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ng1161","volume":"34","author":"M Abifadel","year":"2003","unstructured":"Abifadel M, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet. 2003;34(2):154\u20136.","journal-title":"Nat Genet"},{"issue":"6","key":"6248_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/humu.1380010602","volume":"1","author":"HH Hobbs","year":"1992","unstructured":"Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1992;1(6):445\u201366.","journal-title":"Hum Mutat"},{"issue":"10","key":"6248_CR5","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1373\/clinchem.2004.038026","volume":"50","author":"AJ Whitfield","year":"2004","unstructured":"Whitfield AJ, et al. Lipid disorders and mutations in the APOB gene. Clin Chem. 2004;50(10):1725\u201332.","journal-title":"Clin Chem"},{"key":"6248_CR6","unstructured":"Burnett, J.R., A.J. Hooper, and R.A. Hegele, APOB-Related Familial Hypobetalipoproteinemia, in GeneReviews((R)). 1993: Seattle (WA)."},{"issue":"4","key":"6248_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.029454","volume":"42","author":"SW Fouchier","year":"2005","unstructured":"Fouchier SW, et al. High frequency of APOB gene mutations causing familial hypobetalipoproteinaemia in patients of Dutch and Spanish descent. J Med Genet. 2005;42(4): e23.","journal-title":"J Med Genet"},{"issue":"9","key":"6248_CR8","doi-asserted-by":"publisher","first-page":"6453","DOI":"10.1074\/jbc.M109.060467","volume":"285","author":"S Zhong","year":"2010","unstructured":"Zhong S, et al. Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. J Biol Chem. 2010;285(9):6453\u201364.","journal-title":"J Biol Chem"},{"issue":"2","key":"6248_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1399-0004.1992.tb03141.x","volume":"42","author":"PJ Talmud","year":"1992","unstructured":"Talmud PJ, et al. A novel truncated apolipoprotein B (apo B55) in a patient with familial hypobetalipoproteinemia and atypical retinitis pigmentosa. Clin Genet. 1992;42(2):62\u201370.","journal-title":"Clin Genet"},{"issue":"4","key":"6248_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.pathol.2020.02.002","volume":"52","author":"KR Napier","year":"2020","unstructured":"Napier KR, et al. Design, development and deployment of a web-based patient registry for rare genetic lipid disorders. Pathology. 2020;52(4):447\u201352.","journal-title":"Pathology"},{"key":"6248_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.574474","volume":"11","author":"M Vrablik","year":"2020","unstructured":"Vrablik M, et al. Genetics of familial hypercholesterolemia: new insights. Front Genet. 2020;11: 574474.","journal-title":"Front Genet"},{"key":"6248_CR12","unstructured":"Pubmed. APOB Mutation. https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=c.7564+APOB. Accessed 3 June 2024."},{"issue":"3","key":"6248_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059916","volume":"8","author":"J Juan-Mateu","year":"2013","unstructured":"Juan-Mateu J, et al. Interplay between DMD point mutations and splicing signals in Dystrophinopathy phenotypes. PLoS ONE. 2013;8(3): e59916.","journal-title":"PLoS ONE"},{"issue":"3","key":"6248_CR14","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1172\/JCI111265","volume":"73","author":"RL Sabina","year":"1984","unstructured":"Sabina RL, et al. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J Clin Invest. 1984;73(3):720\u201330.","journal-title":"J Clin Invest"},{"key":"6248_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1183101","volume":"14","author":"A Bez Batti Angulski","year":"2023","unstructured":"Bez Batti Angulski A, et al. Duchenne muscular dystrophy: disease mechanism and therapeutic strategies. Front Physiol. 2023;14: 1183101.","journal-title":"Front Physiol"},{"issue":"5853","key":"6248_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/296165a0","volume":"296","author":"MJ Rennie","year":"1982","unstructured":"Rennie MJ, et al. Effects of Duchenne muscular dystrophy on muscle protein synthesis. Nature. 1982;296(5853):165\u20137.","journal-title":"Nature"},{"issue":"2","key":"6248_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mus.20586","volume":"34","author":"A Aartsma-Rus","year":"2006","unstructured":"Aartsma-Rus A, et al. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve. 2006;34(2):135\u201344.","journal-title":"Muscle Nerve"},{"issue":"2","key":"6248_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s10038-022-01085-2","volume":"68","author":"I Ahmad","year":"2023","unstructured":"Ahmad I, et al. A novel MAP3K20 mutation causing centronuclear myopathy-6 with fiber-type disproportion in a Pakistani family. J Hum Genet. 2023;68(2):107\u20139.","journal-title":"J Hum Genet"},{"issue":"1","key":"6248_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/brain\/aww257","volume":"140","author":"N Vasli","year":"2017","unstructured":"Vasli N, et al. Recessive mutations in the kinase ZAK cause a congenital myopathy with fibre type disproportion. Brain. 2017;140(1):37\u201348.","journal-title":"Brain"},{"issue":"5","key":"6248_CR20","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216775","volume":"15","author":"D Erdinc","year":"2023","unstructured":"Erdinc D, et al. Pathological variants in TOP3A cause distinct disorders of mitochondrial and nuclear genome stability. EMBO Mol Med. 2023;15(5): e16775.","journal-title":"EMBO Mol Med"},{"issue":"6","key":"6248_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166106","volume":"1867","author":"W Jiang","year":"2021","unstructured":"Jiang W, et al. Predominant cellular mitochondrial dysfunction in the TOP3A gene-caused Bloom syndrome-like disorder. Biochim Biophys Acta (BBA) Mol Bas Diseas. 2021;1867(6): 166106.","journal-title":"Biochim Biophys Acta (BBA) Mol Bas Diseas"},{"issue":"4","key":"6248_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200007","volume":"8","author":"G Primiano","year":"2022","unstructured":"Primiano G, et al. Novel TOP3A variant associated with mitochondrial disease: expanding the clinical spectrum of topoisomerase III alpha-related diseases. Neurol Genet. 2022;8(4): e200007.","journal-title":"Neurol Genet"},{"issue":"9","key":"6248_CR23","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/humu.22611","volume":"35","author":"C Chauveau","year":"2014","unstructured":"Chauveau C, Rowell J, Ferreiro A. A rising titan: TTN review and mutation update. Hum Mutat. 2014;35(9):1046\u201359.","journal-title":"Hum Mutat"},{"issue":"5","key":"6248_CR24","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1373\/clinchem.2011.163543","volume":"58","author":"U Turk","year":"2012","unstructured":"Turk U, et al. A 54-year-old diabetic man with low serum cholesterol. Clin Chem. 2012;58(5):826\u20139.","journal-title":"Clin Chem"},{"key":"6248_CR25","doi-asserted-by":"publisher","DOI":"10.5551\/jat.rv22018","author":"T Wakabayashi","year":"2024","unstructured":"Wakabayashi T, et al. Current diagnosis and management of familial hypobetalipoproteinemia 1. J Atheroscler Thromb. 2024. https:\/\/doi.org\/10.5551\/jat.rv22018.","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"6248_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.7326\/M17-0188","volume":"167","author":"JL Vassy","year":"2017","unstructured":"Vassy JL, et al. The impact of whole-genome sequencing on the primary care and outcomes of healthy adult patients: a pilot randomized trial. Ann Intern Med. 2017;167(3):159\u201369.","journal-title":"Ann Intern Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-06248-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06248-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06248-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:08:37Z","timestamp":1793923717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-06248-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6248"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-06248-9","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The patient has provided consent in writing to have information about their medical history.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"693"}}